State Street Corp Summit Therapeutics Inc. Transaction History
State Street Corp
- $2.47 Trillion
- Q4 2024
A detailed history of State Street Corp transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, State Street Corp holds 5,602,910 shares of SMMT stock, worth $104 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,602,910
Previous 3,468,514
61.54%
Holding current value
$104 Million
Previous $76 Million
31.66%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding SMMT
# of Institutions
233Shares Held
83.1MCall Options Held
1.66MPut Options Held
2.56M-
Baker Bros. Advisors LP New York, NY24.4MShares$453 Million4.83% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$216 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$146 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.56MShares$122 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA3.2MShares$59.3 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.73B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...